COMPOSITIONS FOR DIABETES

• Main Authors: HIDAKA, TAKAYOSHI, KAWABE, TAIZO, FUJII, KENJI, HOSOE, KAZUNORI
• Format: Patent
• Language: English; French; Japanese
• Published: 25.09.2003
• Edition: 7
• Subjects: FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

It is intended to provide compositions which have an effect of improving glucose tolerance in patients with hyperglycemia due to diabetes or those showing glucose tolerance disorder and thus being in danger of suffering from diabetes, thus seemingly contribute to the achievement of favorable blood glucose control and the prevention of complications of diabetes, and, furthermore, can be continuously administered over a long time because of having a high safety. By using a composition containing a coenzyme Q (in particular, reduced coenzyme Q10) as the main component, it becomes possible to improve worsened glucose tolerance in a patient with diabetes or the like, achieve favorable blood glucose control and lower the blood glycohemoglobin level. L'invention concerne des compositions améliorant la tolérance au glucose chez des patients atteints d'hyperglycémie due au diabète ou de troubles de la tolérance au glucose, ce qui les rend susceptibles de souffrir de diabète. Ces compositions semblent contribuer à l'obtention d'un équilibre favorable du glucose sanguin et à la prévention des complications du diabète et peuvent, de plus, être administrées sur une durée prolongée, étant donné leur absence de risques. L'utilisation d'une composition contenant un coenzyme Q (en particulier, un coenzyme Q réduit) en tant que constituant principal, permet d'améliorer une tolérance au glucose déficitaire chez un patient atteint d'une maladie, telle que le diabète, d'obtenir un équilibre favorable du glucose sanguin et d'abaisser le niveau de glycohémoglobine sanguine.